These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 30006168)
1. Synthesis, in vitro antiproliferative activity, and kinase inhibitory effects of pyrazole-containing diarylureas and diarylamides. El-Gamal MI; Park BJ; Oh CH Eur J Med Chem; 2018 Aug; 156():230-239. PubMed ID: 30006168 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, in vitro Antiproliferative and Antiinflammatory Activities, and Kinase Inhibitory effects of New 1,3,4-triarylpyrazole Derivatives. El-Gamal MI; Abdel-Maksoud MS; Gamal El-Din MM; Shin JS; Lee KT; Yoo KH; Oh CH Anticancer Agents Med Chem; 2017; 17(1):75-84. PubMed ID: 27334850 [TBL] [Abstract][Full Text] [Related]
3. Design and synthesis of new potent anticancer benzothiazole amides and ureas featuring pyridylamide moiety and possessing dual B-Raf(V600E) and C-Raf kinase inhibitory activities. El-Damasy AK; Lee JH; Seo SH; Cho NC; Pae AN; Keum G Eur J Med Chem; 2016 Jun; 115():201-16. PubMed ID: 27017549 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and broad-spectrum antiproliferative activity of diarylamides and diarylureas possessing 1,3,4-oxadiazole derivatives. Gamal El-Din MM; El-Gamal MI; Abdel-Maksoud MS; Yoo KH; Oh CH Bioorg Med Chem Lett; 2015 Apr; 25(8):1692-1699. PubMed ID: 25801936 [TBL] [Abstract][Full Text] [Related]
5. New diarylureas and diarylamides containing 1,3,4-triarylpyrazole scaffold: Synthesis, antiproliferative evaluation against melanoma cell lines, ERK kinase inhibition, and molecular docking studies. Choi WK; El-Gamal MI; Choi HS; Baek D; Oh CH Eur J Med Chem; 2011 Dec; 46(12):5754-62. PubMed ID: 22014559 [TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of new RAF kinase-inhibiting antiproliferative quinoline derivatives. Part 2: Diarylurea derivatives. El-Gamal MI; Khan MA; Tarazi H; Abdel-Maksoud MS; Gamal El-Din MM; Yoo KH; Oh CH Eur J Med Chem; 2017 Feb; 127():413-423. PubMed ID: 28088086 [TBL] [Abstract][Full Text] [Related]
8. New triarylpyrazoles as broad-spectrum anticancer agents: design, synthesis, and biological evaluation. El-Gamal MI; Park YS; Chi DY; Yoo KH; Oh CH Eur J Med Chem; 2013 Jul; 65():315-22. PubMed ID: 23732996 [TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel 5-phenyl-1H-pyrazole derivatives as potential BRAF(V600E) inhibitors. Wang SF; Zhu YL; Zhu PT; Makawana JA; Zhang YL; Zhao MY; Lv PC; Zhu HL Bioorg Med Chem; 2014 Nov; 22(21):6201-8. PubMed ID: 25267006 [TBL] [Abstract][Full Text] [Related]
10. New diarylamides and diarylureas possessing 8-amino(acetamido)quinoline scaffold: synthesis, antiproliferative activities against melanoma cell lines, kinase inhibition, and in silico studies. Koh EJ; El-Gamal MI; Oh CH; Lee SH; Sim T; Kim G; Choi HS; Hong JH; Lee SG; Yoo KH Eur J Med Chem; 2013; 70():10-21. PubMed ID: 24128410 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and in vitro antiproliferative and kinase inhibitory effects of pyrimidinylpyrazole derivatives terminating with arylsulfonamido or cyclic sulfamide substituents. Gamal El-Din MM; El-Gamal MI; Abdel-Maksoud MS; Yoo KH; Baek D; Choi J; Lee H; Oh CH J Enzyme Inhib Med Chem; 2016; 31(sup2):111-122. PubMed ID: 27255180 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of bis-aryl ureas and amides based on 2-amino-3-purinylpyridine scaffold as DFG-out B-Raf kinase inhibitors. Yang W; Chen Y; Zhou X; Gu Y; Qian W; Zhang F; Han W; Lu T; Tang W Eur J Med Chem; 2015 Jan; 89():581-96. PubMed ID: 25462267 [TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of N-(4-aminopyridin-2-yl)amides as B-Raf(V600E) inhibitors. Li X; Shen J; Tan L; Zhang Z; Gao D; Luo J; Cheng H; Zhou X; Ma J; Ding K; Lu X Bioorg Med Chem Lett; 2016 Jun; 26(12):2760-2763. PubMed ID: 27155899 [TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of a new series of highly potent RAF kinase-inhibiting triarylpyrazole derivatives possessing antiproliferative activity against melanoma cells. Khan MA; El-Gamal MI; Tarazi H; Choi HS; Oh CH Future Med Chem; 2016 Dec; 8(18):2197-2211. PubMed ID: 27845592 [TBL] [Abstract][Full Text] [Related]
16. New diarylureas and diarylamides possessing acet(benz)amidophenyl scaffold: design, synthesis, and antiproliferative activity against melanoma cell line. Kim HJ; Cho HJ; Kim H; El-Gamal MI; Oh CH; Lee SH; Sim T; Hah JM; Yoo KH Bioorg Med Chem Lett; 2012 May; 22(9):3269-73. PubMed ID: 22460030 [TBL] [Abstract][Full Text] [Related]
17. A new series of diarylamides possessing quinoline nucleus: Synthesis, in vitro anticancer activities, and kinase inhibitory effect. El-Gamal MI; Khan MA; Abdel-Maksoud MS; Gamal El-Din MM; Oh CH Eur J Med Chem; 2014 Nov; 87():484-92. PubMed ID: 25282271 [TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, in vitro antiproliferative evaluation, and kinase inhibitory effects of a new series of imidazo[2,1-b]thiazole derivatives. Abdel-Maksoud MS; Kim MR; El-Gamal MI; Gamal El-Din MM; Tae J; Choi HS; Lee KT; Yoo KH; Oh CH Eur J Med Chem; 2015 May; 95():453-63. PubMed ID: 25841200 [TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, in-vitro antiproliferative activity and kinase profile of new picolinamide based 2-amido and ureido quinoline derivatives. El-Damasy AK; Seo SH; Cho NC; Kang SB; Pae AN; Kim KS; Keum G Eur J Med Chem; 2015 Aug; 101():754-68. PubMed ID: 26218653 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and evaluation of novel diaryl urea derivatives as potential antitumor agents. Lu C; Tang K; Li Y; Li P; Lin Z; Yin D; Chen X; Huang H Eur J Med Chem; 2014 Apr; 77():351-60. PubMed ID: 24675135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]